Porton Pharma Solutions Ltd. (300363.SZ)
CNY 17.08
(0.59%)
CNY 17.08
(0.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.66 Billion | 7.03 Billion | 3.1 Billion | 2.07 Billion | 1.55 Billion | 1.18 Billion |
| Cost of Revenue | 2.23 Billion | 3.37 Billion | 1.82 Billion | 1.2 Billion | 964.27 Million | 788.37 Million |
| Gross Profit | 1.43 Billion | 3.65 Billion | 1.28 Billion | 863.52 Million | 587.01 Million | 396.49 Million |
| Operating Expenses | 1.16 Billion | 1.36 Billion | 646.68 Million | 453.5 Million | 363.42 Million | 264.18 Million |
| Selling, General and Administrative Expenses | 239.1 Million | 348.73 Million | 168.02 Million | 124.18 Million | 95.13 Million | 75.24 Million |
| Research and Development Expenses | 452.22 Million | 519.5 Million | 263.82 Million | 157.83 Million | 122.55 Million | 76.19 Million |
| Other Expenses | 476.87 Million | 500.55 Million | 214.84 Million | 171.48 Million | 145.72 Million | -21.09 Million |
| Cost and Expenses | 3.39 Billion | 4.74 Billion | 2.46 Billion | 1.66 Billion | 1.32 Billion | 1.05 Billion |
| Operating Income | 268.91 Million | 2.26 Billion | 565.59 Million | 352.23 Million | 265.79 Million | 153.96 Million |
| Interest Expense | 46.67 Million | 27.72 Million | 21.7 Million | 24.38 Million | 42.76 Million | 62.78 Million |
| Income Tax Expense | 71.04 Million | 309.38 Million | 73.24 Million | 40.55 Million | 13.79 Million | 21.42 Million |
| Earnings before Tax | 246.56 Million | 2.24 Billion | 548.83 Million | 363.74 Million | 193.41 Million | 132.86 Million |
| Net Income | 266.85 Million | 2 Billion | 523.91 Million | 324.41 Million | 185.55 Million | 124.49 Million |
| Earnings Per Share Basic | 0.49 | 3.70 | 0.98 | 0.61 | 0.35 | 0.26 |
| Earnings Per Share Diluted | 0.49 | 3.69 | 0.98 | 0.61 | 0.35 | 0.26 |
| Weighted Average Shares Outstanding | 544.61 Million | 542.01 Million | 535.97 Million | 534.32 Million | 534.32 Million | 478.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 544.61 Million | 543.48 Million | 535.97 Million | 534.32 Million | 534.32 Million | 478.82 Million |
| Gross Margin | 0.39 | 0.52 | 0.41 | 0.42 | 0.38 | 0.33 |
| EBIT Margin | 0.17 | 0.37 | 0.27 | 0.26 | 0.25 | 0.26 |
| Profit Margin | 0.07 | 0.29 | 0.17 | 0.16 | 0.12 | 0.11 |
| EBITDA | 639.82 Million | 2.53 Billion | 762.73 Million | 520.93 Million | 354.47 Million | 320.29 Million |
| Earnings Before Tax Margin | 0.07 | 0.32 | 0.18 | 0.17 | 0.17 | 0.13 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 773.15 Million | 666.15 Million | 673.78 Million | 625.68 Million | 3.62 Billion | 698.25 Million |
| Cost of Revenue | 532.81 Million | 565.15 Million | 570.35 Million | 560.77 Million | 2.29 Billion | 400.29 Million |
| Gross Profit | 240.34 Million | 101 Million | 103.43 Million | 64.9 Million | 1.32 Billion | 297.96 Million |
| Operating Expenses | 235.78 Million | 217.78 Million | 240.32 Million | 218.24 Million | 1.04 Billion | 262.61 Million |
| Selling, General and Administrative Expenses | 369.37 Million | 130.26 Million | 156.05 Million | 134.44 Million | - | 380.7 Million |
| Research and Development Expenses | 98.06 Million | 66.83 Million | 84.43 Million | 18.71 Million | - | 113.91 Million |
| Other Expenses | -231.66 Million | -20.68 Million | 157.84 Thousand | -65.09 Million | -54.27 Million | -15.36 Million |
| Cost and Expenses | 768.6 Million | 782.93 Million | 810.67 Million | 779.01 Million | 3.33 Billion | 662.9 Million |
| Operating Income | -48.78 Million | -116.78 Million | -136.89 Million | -153.33 Million | 283.28 Million | 12.65 Million |
| Interest Expense | 15.08 Million | 15.67 Million | 15.53 Million | 17.95 Million | 44.15 Million | 10.04 Million |
| Income Tax Expense | -31.44 Thousand | -13.06 Million | -18.21 Million | 533.91 Thousand | 71.04 Million | 3.79 Million |
| Earnings before Tax | -50.46 Million | -102.74 Million | -136.14 Million | -183.02 Million | 267.18 Million | 8.05 Million |
| Net Income | -36.39 Million | -75.16 Million | -94.87 Million | -184.99 Million | 266.85 Million | 41.48 Million |
| Earnings Per Share Basic | -0.07 | -0.14 | -0.17 | -0.34 | - | 0.08 |
| Earnings Per Share Diluted | -0.07 | -0.14 | -0.17 | -0.34 | - | 0.08 |
| Weighted Average Shares Outstanding | 519.9 Million | 546.03 Million | 558.06 Million | 546.12 Million | 546.12 Million | 546.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 519.9 Million | 546.03 Million | 558.06 Million | 546.12 Million | 546.12 Million | 546.12 Million |
| Gross Margin | 0.31 | 0.15 | 0.15 | 0.10 | 0.37 | 0.43 |
| EBIT Margin | -0.05 | -0.01 | -0.18 | -0.08 | - | 0.01 |
| Profit Margin | -0.05 | -0.11 | -0.14 | -0.30 | 0.07 | 0.06 |
| EBITDA | -35.38 Million | -8.13 Million | -123.58 Million | -49.07 Million | - | 4.45 Million |
| Earnings Before Tax Margin | -0.06 | -0.18 | -0.20 | -0.25 | 0.08 | 0.02 |
2521
OEL
JDWPF
GENUSPAPER
VIO
CFPUF